Cite
APA Citation
Asnaghi, V., Lin, H., Hu, N., Smith, J., Cho, W., & Ostrowitzki, S. (n.d.). [O2–17–06]: SAFETY AND TOLERABILITY OF CRENEZUMAB IN MILD‐TO‐MODERATE AD PATIENTS TREATED WITH ESCALATING DOSES FOR UP TO 25 MONTHS. Alzheimer's & dementia, 13, P602. http://access.bl.uk/ark:/81055/vdc_100103407991.0x00001d